Emotional Distress in Patients With Metastatic Breast Cancer in First Line of Therapy
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
Few data about the impact of emotional distress (ED) on treatment efficacy in patients with metastatic breast cancer (mBC) are available. Aim of this study is to assess the outcomes of patients with mBC receiving first-line treatment according to the presence of baseline ED.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Osoby powyżej 18. roku życia.
- •Potwierdzony rak piersi.
- •Brak wcześniejszego leczenia z powodu zaawansowanego raka piersi.
- •Leczenie zgodne ze standardami dla danego typu raka piersi (np. leki w połączeniu z chemioterapią lub terapie celowane).
- •Widoczne zmiany chorobowe na badaniach obrazowych.
- •Zgoda na udział w badaniu.
✗ Disqualifies
- •Poważne problemy ze zdrowiem psychicznym, które utrudniają zrozumienie zasad badania.
- •Niezdolność do wypełniania ankiet.
- •Inny nowotwór wykryty w ciągu ostatnich 3 lat.
- •Aktywne przerzuty do mózgu.
- •Przyjmowanie leków przeciwdepresyjnych lub przeciwlękowych.
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- June 17, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (37)
Ospedali Riuniti di Ancona
Ancona, Italy
CRO (Centro di Riferimento Oncologico)
Aviano, Italy
Azienda Usl Toscana centro - Ospedale Santa Maria Annunziata
Bagno a Ripoli, Italy
IRCCS Istituto Tumori Giovanni Paolo II
Bari, Italy
ASST Papa Giovanni XXIII
Bergamo, Italy
ASST Spedali Civili
Brescia, Italy
Ospedale A. Perrino
Brindisi, Italy
ASST della Valle Olona
Busto Arsizio, Italy
Ospedale Valduce
Como, Italy
Ospedale Careggi
Florence, Italy
Ospedale Policlinico San Martino
Genova, Italy
AOU Gaetano Martino di Messina
Messina, Italy
European Institute of Oncology
Milan, Italy
ASST Fatebenefratelli Sacco
Milan, Italy
Fondazione IRCCS Istituto Nazionale dei Tumori
Milan, Italy
IRCCS Ospedale San Raffaele
Milan, Italy
Ospedale Niguarda
Milan, Italy
Ospedale San Giuseppe MultiMedica
Milan, Italy
Policlinico di Milano
Milan, Italy
Azienda Ospedaliero-Universitaria di Modena
Modena, Italy
Azienda Ospedaliera Universitaria Federico II
Naples, Italy
Istituto Nazionale Tumori IRCCS Fondazione G. Pascale
Naples, Italy
Ospedale Maggiore di Novara
Novara, Italy
Policlinico Universitario Paolo Giaccone
Palermo, Italy
Policlinico San Matteo
Pavia, Italy
Azienda Ospedaliero Universitaria Pisana
Pisa, Italy
Azienda Ospedaliero Universitaria Pisana
Pisa, Italy
Azienda Usl Toscana centro - Ospedale di Prato Santo Stefano
Prato, Italy
Ospedale Infermi
Rimini, Italy
Policlinico Universitario Campus Bio-Medico
Roma, Italy
Policlinico Umberto I
Rome, Italy
Policlinico Universitario Agostino Gemelli IRCCS
Rome, Italy
Azienda Ospedaliero Universitaria di Sassari
Sassari, Italy
ASL CN2 - Ospedale Michele e Pietro Ferrero
Verduno, Italy
Azienda Ospedaliera Universitaria Integrata Verona
Verona, Italy
Ospedale Sacro Cuore Don Calabria - Negrar
Verona, Italy
ASST Brianza
Vimercate, Italy
Trial contact
Gabriella Pravettoni, MD, PhD
Mara Negri
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/1/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.